Quarterly Financial Information (unaudited)

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information (unaudited)

Quarterly Financial Information (unaudited)

11. Quarterly Financial Information (unaudited)

	First  Quarter			Second  Quarter			Third  Quarter			Fourth  Quarter			Total Year
2014:
Research and development expenses	$	2,149		$	2,805		$	1,569		$	2,167		$	8,690
General and administrative expenses	$	517		$	458		$	868		$	1,387		$	3,230
Net loss	$	(2,235	)	$	(3,323	)	$	(1,668	)	$	(3,607	)	$	(10,833	)
Cumulative preferred stock dividends	$	(1,071	)	$	(1,102	)	$	(372	)	—			$	(2,543	)
Net loss applicable to common shareholders	$	(3,306	)	$	(4,425	)	$	(2,040	)	$	(3,607	)	$	(13,378	)
Net loss per share, basic and diluted	$	(7.09	)	$	(7.98	)	$	(0.22	)	$	(0.26	)	$	(2.17	)
2013:
Research and development expenses	$	747		$	1,327		$	1,008		$	1,068		$	4,150
General and administrative expenses	$	180		$	314		$	313		$	422		$	1,229
Net loss	$	(970	)	$	(1,682	)	$	(1,224	)	$	(1,394	)	$	(5,270	)
Cumulative preferred stock dividends	$	(786	)	$	(940	)	$	(1,029	)	$	(1,049	)	$	(3,804	)
Net loss applicable to common shareholders	$	(1,756	)	$	(2,622	)	$	(2,253	)	$	(2,443	)	$	(9,074	)
Net loss per share, basic and diluted	$	(3.82	)	$	(5.66	)	$	(4.58	)	$	(5.54	)	$	(19.60	)